Stocktoria
Co-Diagnostics, Inc. CODX
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2017-07-12
Co-Diagnostics, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 64.3% | 74.5% | 38.6% | 84.0% | 88.2% |
| Operating margin | -8058.8% | -1023.7% | -626.9% | -78.8% | 47.1% |
| Net margin | -7533.6% | -961.4% | -518.7% | -41.6% | 37.5% |
| FCF margin | -4793.2% | -763.8% | -344.2% | 15.0% | 41.3% |
| Return on assets | -189.5% | -59.2% | -37.1% | -11.6% | 22.9% |
| Return on equity | -227.3% | -69.9% | -41.3% | -12.4% | 27.3% |
| Current ratio | 3.87 | 4.41 | 10.81 | 23.94 | 9.14 |
| Revenue growth | -84.1% | -42.5% | -80.1% | -65.0% | 31.3% |
Source: SEC EDGAR filings · CIK 0001692415 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.